+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
FEMALE
ID05585476

Evaluating Microfractionated C02 Laser and Topical Regenerative Therapy for Vulvo-vaginal Atrophy in Breast Cancer Survivors

Led by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Updated on 2026-09-29

195

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate treatments for vulvo-vaginal atrophy in women with a history of breast cancer who cannot use hormonal therapies. It focuses on assessing the effectiveness and safety of a combined microfractionated C02 laser therapy and a non-hormonal topical regenerative treatment compared to each treatment alone. The study also examines the prevalence of genitourinary syndrome in these patients and its impact on their quality of life. Participants are randomly assigned to one of three groups a combination of laser treatment plus regenerative topical gel, regenerative topical gel alone, or laser treatment alone. The laser therapy involves three sessions spaced over several weeks, while the topical gel is applied twice daily for 36 months. The study follows a single-blind design where participants do not know their assigned treatment. Treatments are delivered through vaginal and vulvar applications using specialized devices and gels. During the study, participants will attend eight visits including treatment sessions and follow-ups over several months. Assessments include physical exams, gynecological ultrasounds, questionnaires on symptoms and quality of life, skin measurements, vaginal samples, and biopsies. Adverse events will be carefully monitored. Researchers will measure vulvo-vaginal symptoms and their intensity from baseline to six months after treatment. Safety, tolerability, and effects on urinary symptoms are also evaluated throughout the study.

CONDITIONS

Brief Title

A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients.

Research Team

A

Amalia Cañadas Molina

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here